| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/01/1992 | CA2090620A1 Methods of treating, diagnosing and monitoring therapies from levels of human oubain-like factor and antibody thereof |
| 03/01/1992 | CA2090478A1 Human interferon- 4-134, functional equivalents thereof and methods of using and compositions employing these materials |
| 03/01/1992 | CA2090470A1 Peptide antigens and immunoassays, test kits and vaccines using the same |
| 03/01/1992 | CA2090464A1 Method for treating endotoxin shock using anti-adhesion antibodies |
| 03/01/1992 | CA2090317A1 Homoconjugated immunoglobulins |
| 03/01/1992 | CA2089761A1 Method and compositions for diagnosing and treating chronic fatique immunodysfunction syndrome |
| 03/01/1992 | CA2089375A1 Inhibition of metastatis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies |
| 02/28/1992 | WO1992003538A1 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA |
| 02/28/1992 | WO1992003459A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 02/28/1992 | WO1992003145A1 Method of treating viral infection |
| 02/28/1992 | CA2090486A1 Human zona pellucida protein zp3 |
| 02/28/1992 | CA2090469A1 Ligand for the c-kit receptor and methods of use thereof |
| 02/28/1992 | CA2090401A1 Method of treating viral infection |
| 02/26/1992 | WO1992003458A1 Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines |
| 02/26/1992 | EP0472181A2 5-Amine substituted adenosine analogs as immunosuppressants |
| 02/26/1992 | EP0471954A2 Immunogenic conjugates of nontoxic oligosaccharide derived from bordetella pertussis lipooligosaccharide |
| 02/26/1992 | EP0471796A1 Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter |
| 02/26/1992 | EP0471778A1 Herpes simplex virus type 2-glycoprotein g proteins and polypeptides |
| 02/26/1992 | EP0471752A1 Polypeptides of feline t-cell lymphotropic lentivirus |
| 02/26/1992 | CN1058990A Protein structure of plant toxin gelonin |
| 02/26/1992 | CA2090335A1 Non-a, non-b hepatitis virus antigen, diagnostic methods and vaccines |
| 02/25/1992 | US5091542 Trivalent coupling agents for linking fab fragments to form bifunctional and trifunctional antibody-like compounds |
| 02/25/1992 | US5091512 Fibrinogen-specific monoclonal antibody |
| 02/25/1992 | US5091318 For detection of immunoglobulins in test samples |
| 02/25/1992 | US5091313 Antigenic epitopes of IgE present on B cell but not basophil surface |
| 02/25/1992 | US5091308 Process for the enzymatic dispersal of mycobacterium bovis - bcg |
| 02/25/1992 | US5091303 Binding of monoclonal antibody to pure p29 protein |
| 02/25/1992 | US5091302 Polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic applications thereof |
| 02/25/1992 | US5091188 Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| 02/25/1992 | US5091187 Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| 02/25/1992 | US5091181 Plant extract; used for preventing complete immune system dysfunction |
| 02/25/1992 | US5091091 Cancer therapy |
| 02/25/1992 | CA1296252C Method and composition for prophylaxis and treatment of viral infections |
| 02/24/1992 | WO1992003158A1 Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom |
| 02/24/1992 | CA2089888A1 Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom |
| 02/21/1992 | CA2067337A1 Methods for producing rna viruses from cdna |
| 02/20/1992 | WO1992002823A1 Thrombocytopenia determination |
| 02/20/1992 | WO1992002624A1 Cloning and expression of toxoplasma antigens and use of recombinant antigens |
| 02/20/1992 | WO1992002623A1 CLONING AND EXPRESSION OF A RHOPTRY ASSOCIATED PROTEIN OF $i(P.FALCIPARUM) |
| 02/20/1992 | WO1992002555A1 A fibronectin binding peptide |
| 02/20/1992 | WO1992002554A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
| 02/20/1992 | WO1992002552A1 Granulocyte-inhibiting polypeptide |
| 02/20/1992 | WO1992002548A1 Recombinant baculovirus expressing proteins e and ns1 of flaviviridae viruses and flaviviridae-related viruses |
| 02/20/1992 | WO1992002255A1 New linker for bioactive agents |
| 02/20/1992 | WO1992002252A1 The gene encoding equine herpesvirus type 1 glycoprotein d, its gene product, antibodies and their uses |
| 02/20/1992 | WO1992002250A1 Cross-reactive influenza a immunization |
| 02/20/1992 | WO1992002249A1 PROCESS FOR INHIBITING THE FUNCTION OF PROTECTED EXTRA-CELLULAR mRNAs OF CANCEROUS ORIGIN TO PROVIDE PROPHYLAXY AGAINST MALIGNANT DISEASES AND THEIR RELAPSES |
| 02/20/1992 | WO1992002243A1 Liposomes that provide thymic dependent help to weak vaccine antigens |
| 02/20/1992 | WO1991019736A3 Cancer-associated scm-recognition factor, preparation and method of use |
| 02/20/1992 | WO1991004059A3 Method and useful apparatus for preparing pharmaceutical compositions |
| 02/20/1992 | CA2088246A1 Gene encoding equine herpesvirus type i glycoprotein d, its gene product, antibodies and their uses |
| 02/20/1992 | CA2088164A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
| 02/19/1992 | EP0471457A2 Herpesvirus-based viral vector which expresses a foot & mouth disease virus epitope |
| 02/19/1992 | EP0471453A2 Cyclic HIV principal neutralizing determinant peptides |
| 02/19/1992 | EP0471407A2 New embodiments of the HIV principal neutralizing determinant |
| 02/19/1992 | EP0471356A1 Antigenic peptide for detecting anti-hepatitis C virus antibodies and use thereof |
| 02/19/1992 | EP0471205A1 Monoclonal antibodies which bind TRK proto-oncogene protein |
| 02/19/1992 | EP0471177A2 Filamentous hemagglutinin of bordetella pertussis as a carrier molecule for conjugate vaccines |
| 02/19/1992 | EP0471028A1 Highly cytopathogenic hiv-ndk retrovirus, dna fragments of this retrovirus, method for preparing a protein and/or an enzyme of this virus, and the applications of these |
| 02/19/1992 | CN1058781A Pyrano heterocyclic anthracycline analogs |
| 02/18/1992 | WO1992003159A1 New peptides and their use |
| 02/18/1992 | US5089605 Immobilized immunoglobulin-binding proteins |
| 02/18/1992 | US5089603 Antigenic epitopes present on membrane-bound but not secreted iga |
| 02/18/1992 | US5089262 Diagnosis, therapy |
| 02/18/1992 | CA2089660A1 New peptides and their use |
| 02/18/1992 | CA1295985C Method for separating and purifying protein antigens from bordetella bacteria |
| 02/18/1992 | CA1295938C Monoclonal antibodies effective in promoting growth |
| 02/16/1992 | WO1992003563A1 Method for modifying the cell, tissue or host tropism of a microorganism; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine |
| 02/16/1992 | CA2089484A1 Method for modifying the cell tissue or host tropism of a microorganism; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine |
| 02/16/1992 | CA2048244A1 Monoclonal antibodies which bind trk proto-oncogene protein |
| 02/15/1992 | WO1992003144A1 Protein structure of the plant toxin gelonin |
| 02/15/1992 | CA2048895A1 Antigenic peptide for detecting anti-hepatitis c virus antibodies and use thereof |
| 02/14/1992 | WO1992003466A1 Lymphokine 154 |
| 02/14/1992 | CA2089258A1 Lymphokine 154 |
| 02/14/1992 | CA2048917A1 Filamentous hemagglutinin of bordetella pertussis as a carrier molecule for conjugate vaccines |
| 02/14/1992 | CA2048871A1 Immunogenic conjugates of nontoxic oligosaccharide derived from bordetella pertussis lipooligosaccharide |
| 02/14/1992 | CA2048594A1 Embodiments of the hiv principal neutralizing determinant |
| 02/13/1992 | DE4125188A1 Granulocyten hemmendes polypeptid Granulocyte inhibitory polypeptide |
| 02/13/1992 | DE4122906A1 Divested bacteria prepn. for vaccines - by binding partially oxidised polysaccharide to surface, and coating modified bacteria with viral or bacterial protein or polypeptide |
| 02/13/1992 | DE4025499A1 Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen Use of antibodies BR55-2, derivatives thereof, and fragments conjugate on HIV infections |
| 02/12/1992 | EP0470565A1 Peptides with antigenic determinant characteristic for alpha 1-microglobulin |
| 02/12/1992 | EP0470205A1 New human parvovirus peptides with disulfide bridge for immunization or diagnosis |
| 02/12/1992 | CN1058598A New linker for bioactive agents |
| 02/11/1992 | US5087696 Conjugate compound |
| 02/11/1992 | US5087616 Linked by biodegradable polymer to epidermal growth factor |
| 02/11/1992 | US5087560 Monoclonal antibody for use in drug resistant cancers and production thereof |
| 02/11/1992 | CA1295564C Recombinant plasmid inserted with herpes simplex virus gene |
| 02/11/1992 | CA1295562C DNA SEQUENCES CODING FOR THE DR.beta.-CHAIN LOCUS OF THE HUMAN LYMPHOCYTE ANTIGEN COMPLEX AND POLYPEPTIDES, DIAGNOSTIC TYPING PROCESSES AND PRODUCTS RELATED THERETO |
| 02/11/1992 | CA1295561C Production of herpes simplex viral proteins |
| 02/09/1992 | WO1992002640A1 Cannabinoid receptor |
| 02/09/1992 | WO1992002621A2 Allergens of alder pollen and applications thereof |
| 02/09/1992 | CA2087844A1 Cannabinoid receptor |
| 02/09/1992 | CA2067144A1 Allergens of alder pollen and applications thereof |
| 02/07/1992 | WO1992002549A1 Plasmodium falciparum antigen for eliciting protective antibodies for use in vaccines |
| 02/07/1992 | CA2088988A1 Plasmodium falciparum antigen for eliciting protective antibodies for use in vaccines |
| 02/07/1992 | CA2048305A1 Peptides with a characteristic antigenic determinant for alphal-microglobulin |
| 02/06/1992 | WO1992001816A1 Human herpesvirus-7 |
| 02/06/1992 | WO1992001796A1 Mycobacterial expression vector |
| 02/06/1992 | WO1992001791A1 Method of preparation of vaccines, and the use of the vaccines thus prepared |
| 02/06/1992 | WO1992001784A1 Rotavirus reassortant vaccine |